Bumetanide
Rank #331 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$32.4M
Total Cost
735,077
Total Claims
$32.4M
Total Cost
22,315
Prescribers
$44
Cost per Claim
122,522
Beneficiaries
1,262,226
30-Day Fills
$1,451
Avg Cost/Provider
33
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$32.4M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $32.4M total
Top Prescribers of Bumetanide
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Ashar Luqman | Nephrology | Sioux City, IA | 1,306 | $46K |
| 2 | Howard Sherman | Cardiology | Biddeford, ME | 334 | $42K |
| 3 | Neil Kumar | Nephrology | Roseburg, OR | 577 | $41K |
| 4 | Ramy Fayad | Nephrology | Toledo, OH | 369 | $40K |
| 5 | Lin-Wang Dong | Cardiology | Greeley, CO | 645 | $35K |
| 6 | Jonathan Holtz | Advanced Heart Failure and Transplant Cardiology | Altoona, PA | 235 | $28K |
| 7 | Iqbal Masood | Nephrology | Grand Forks, ND | 643 | $28K |
| 8 | Jennifer Swift | Nurse Practitioner | Milwaukee, WI | 325 | $27K |
| 9 | Michelle Montpetit | Cardiology | Winfield, IL | 199 | $25K |
| 10 | Rhonda Bridgewater | Nurse Practitioner | Cedar Rapids, IA | 308 | $23K |
| 11 | Amith Shamir | Nephrology | Butler, PA | 444 | $23K |
| 12 | Emilie Scarbrough | Nurse Practitioner | Findlay, OH | 376 | $23K |
| 13 | Tiffany Sito | Nurse Practitioner | Midland, MI | 329 | $22K |
| 14 | David Williams | Family Practice | Meadville, PA | 1,294 | $22K |
| 15 | Lance Sullenberger | Cardiology | Albany, NY | 597 | $22K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 328 | Mavacamten (Camzyos) | $32.8M | 3,969 |
| 329 | Empagliflozin/Linagliptin (Glyxambi) | $32.6M | 34,331 |
| 330 | Methotrexate Sodium (Methotrexate) | $32.4M | 911,965 |
| 331 | Bumetanide (Bumetanide) | $32.4M | 735,077 |
| 332 | Voxelotor (Oxbryta) | $31.5M | 2,707 |
| 333 | Rivastigmine (Rivastigmine) | $31.4M | 118,567 |
| 334 | Zolpidem Tartrate (Zolpidem Tartrate) | $31.3M | 3,144,599 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology